NovaBridge Biosciences

Approval AI-extracted

Giva

first-line treatment of gastric cancer

Countdown

177days

Approval decision · ~ Dec 31, 2026 estimated

What's at stake A final FDA approval decision on Giva for first-line treatment of gastric cancer is expected ~ Dec 31, 2026.

Primary source · SEC 6-K verified 12h ago

“Giva Initiate randomized global Phase 2 study for 1L treatment of GEA in combo with chemo + PD-1 and have the first patient enrolled 1Q26”